AI NEWS 24
Anthropic Launches Claude Sonnet 5: Enhanced Performance, Lower Cost, and Agentic Capabilities▲ 96Escalating US-China AI Competition Creates Geopolitical Instability▲ 96Open-Source LLM GLM-5.2 Reportedly Outperforms GPT-5.5 at 1/6th the Cost▲ 96Meta to Launch Cloud Business to Monetize Excess AI Computing Capacity▲ 95Global Investment Surges to Meet AI Data Center Power Demand▲ 95Meituan Unveils LongCat-2.0, a Frontier-Scale AI Model Trained Exclusively on Chinese Chips▲ 95China Expands Cyber Targeting Beyond Technology Amid Intensifying AI Competition with U.S.▲ 95Meta's Autodata: AI Models Learn to Self-Generate Training Data▲ 95AI Data Center Capacity Projected to Reach 150 GW by 2030▲ 95Concerns Rise Over AI Models' Potential to Assist Terrorist Attacks▲ 94///Anthropic Launches Claude Sonnet 5: Enhanced Performance, Lower Cost, and Agentic Capabilities▲ 96Escalating US-China AI Competition Creates Geopolitical Instability▲ 96Open-Source LLM GLM-5.2 Reportedly Outperforms GPT-5.5 at 1/6th the Cost▲ 96Meta to Launch Cloud Business to Monetize Excess AI Computing Capacity▲ 95Global Investment Surges to Meet AI Data Center Power Demand▲ 95Meituan Unveils LongCat-2.0, a Frontier-Scale AI Model Trained Exclusively on Chinese Chips▲ 95China Expands Cyber Targeting Beyond Technology Amid Intensifying AI Competition with U.S.▲ 95Meta's Autodata: AI Models Learn to Self-Generate Training Data▲ 95AI Data Center Capacity Projected to Reach 150 GW by 2030▲ 95Concerns Rise Over AI Models' Potential to Assist Terrorist Attacks▲ 94
← Back to Briefing

AI Integration Intensifies Across Pharmaceutical Drug Discovery and Healthcare Management

Importance: 90/1003 Sources

Why It Matters

The substantial investment and collaborative efforts in AI across the pharmaceutical and healthcare sectors are accelerating the drug discovery process and enhancing patient care through more efficient development and management of treatments.

Key Intelligence

  • ■Inductive Bio is deploying AI-powered ADMET prediction models to the Claude platform, enhancing drug discovery efficiency by predicting compound properties.
  • ■Insilico Medicine has partnered with Takeda to strategically advance AI-driven drug discovery initiatives.
  • ■Cigna's Evernorth division announced a $100 million AI program dedicated to optimizing specialty drug management.
  • ■These developments underscore a significant industry trend towards leveraging AI to accelerate drug development, improve predictive capabilities, and refine healthcare delivery.

Source Coverage

Google News - AI & Models
7/2/2026

Inductive Bio Brings AI-Powered ADMET Prediction Models to Claude via New MCP Connector - BioPharma APAC

Google News - AI
7/2/2026

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery - The Manila Times

Google News - AI
7/2/2026

Cigna's Evernorth division announces $100M specialty drug AI program - BenefitsPRO